Detection of Mycobacterium leprae infection employing a combinatorial approach of anti-45 kDa and modified anti-PGL-I antibody detection assays

References

1. Oskam L., Slim E., Buhrer-Sekula S. 2003; Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74:196–205
   [Google Scholar]
2. Parkash O. 2002; Progress towards development of immunoassays for detection of Mycobacterium leprae infection employing 35kDa antigen: an update. Lepr Rev 73:9–19
   [Google Scholar]
3. Parkash O., Kumar A., Nigam A., Franken K. L. M. C., Ottenhoff T. H. M. 2006a; Evaluation of recombinant serine-rich 45kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scand J Immunol 64:450–455 [CrossRef]
   [Google Scholar]
4. Parkash O., Kumar A., Nigam A., Girdhar B. K. 2006b; Detection of antibodies against Mycobacterium leprae culture filtrate protein-10 in leprosy patients. J Med Microbiol 55:1337–1341 [CrossRef]
   [Google Scholar]
5. Parkash O., Pandey R., Kumar A., Kumar A. 2007a; Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients. Lett Appl Microbiol 44:524–530 [CrossRef]
   [Google Scholar]
6. Parkash O., Kumar A., Kumar A., Arora M. L. 2007b; Low temperature incubation improves the performance of anti-phenolic glycolipid-I antibody detecting ELISA in leprosy patients. J Med Microbiol 56:438–440 [CrossRef]
   [Google Scholar]
7. WHO 1988; WHO expert committee on leprosy. World Health Organ Tech Rep Ser 768:1–51
   [Google Scholar]
8. WHO 1998; WHO expert committee on leprosy, Geneva. World Health Organ Tech Rep Ser 874:1–43
   [Google Scholar]
9. WHO 2005; Global strategy for further reducing the leprosy burden and sustaining leprosy control activities. Lepr Rev 76:265–287
   [Google Scholar]